The Acute Effect of Endobarrier Treatment on Glucose Homeostasis in Obese Uncontrolled Diabetic Subjects
The Endobarrier gastrointestinal liner system (by GI Dynamics®) is an endoscopically-delivered device that offers an alternative to gastric bypass surgery.
Endoscopic, Duodenal-Jejunal Bypass Liner Exerts Robust Improvement in Glycemia and Body Weight in Obese Patients with Type 2 Diabetes
The endoscopically delivered duodenal-jejunal bypass liner (DJBL) exhibits robust metabolic effects in obese subjects with type 2 diabetes (T2D).
Duodenal-Jejunal Bypass Liner Implantation Provokes Rapid Weight Loss and Improved Glycemic Control, Accompanied by Elevated Fasting Ghrelin Levels
Endoscopic implantation of a duodenal-jejunal bypass liner (DJBL) is a novel bariatric technique to induce weight loss and remission of type 2 diabetes mellitus.
The Feasibility of Delivering a Duodenal-Jejunal Bypass Liner (EndoBarrier®) Endoscopically with Patients Under Conscious Sedation
This study was performed to determine the safety, efficacy, and feasibility of delivering the DJBL with the patient under conscious sedation (CS).
Position Paper of Scientific Societies for Recommended Usage of Endoscopic Biliodigestive Diversion in Germany – DDG/DGAV/DGVS
We recommend consideration of the DJBS as a therapy alternative for the treatment of adult patients (minimum age: 18 years) with type 2 diabetes mellitus and overweight (BMI 30 – 45) when these patients cannot reach their individual therapy goals over a period of 3 to 6 months under the therapy...
To report Type 2 diabetes-related outcomes after the implantation of a duodenal-jejunal bypass liner device and to investigate the role of proximal gut exclusion from food in glucose homeostasis using the model of this device.
Endoscopic Duodenal-Jejunal Bypass Liner Rapidly Improves Plasma Parameters of Nonalcoholic Fatty Liver Disease
Bariatric surgery reduces nonalcoholic fatty liver disease (NAFLD). We investigated the effects of duodenal-jejunal bypass liner (DJBL), nonsurgical bariatric device, on plasma parameters of NAFLD.
Baseline Glycated Hemoglobin Levels are Associated with Duodenal-Jejunal Bypass Liner-Induced Weight Loss in Obese Patients
We sought to identify clinical factors associated with weight loss in obese patients treated with the DJBL for 1 year.
To gain insight into the mediators involved, we investigated factors regulating glucose homeostasis in patients with type 2 diabetes treated with the novel endoscopic duodenal-jejunal bypass liner (DJBL).
The Duodenal-Jejunal Bypass Sleeve (EndoBarrier Gastrointestinal Liner) for Weight Loss and Treatment of Type 2 Diabetes
We conducted a nonsystematic review on worldwide articles published on the MEDLINE database to ascertain progress in the development and use of the EndoBarrier.